/Companies

Recida Therapeutics

Menlo Park, US · Founded 2016 · Delaware corporation · 2 known investors

Find your way into Recida Therapeutics

Sign up to see every warm intro you have to Recida Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Recida Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

YG
Yigong GeNamed on SEC filing
MS
Michael SavinoNamed on SEC filing
DS
David SocksNamed on SEC filing

Board

PHPatrick Heron
Patrick HeronBoard directorManaging Partner at Frazier Life Sciences

Investors · 2

Reported raises · per SEC filings

Form D private placements

$5.7M disclosed across 1 round · 2018

▶$5.7MraisedJul 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Patrick HeronDirector
  • Yigong GeExecutive Officer, Director
  • Michael SavinoExecutive Officer
  • David SocksDirector
Offering amount
$10.7M
Amount sold
$5.7M
First sale
Jun 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Recida Therapeutics's investors?
Recida Therapeutics's investors include Frazier Healthcare Partners, Frazier Life Sciences.
How much funding has Recida Therapeutics raised?
Recida Therapeutics has disclosed $5.7M raised across 1 round.
Where is Recida Therapeutics headquartered?
Recida Therapeutics is headquartered in Menlo Park, US.